- Home
- SLNO vs ASB Comparison
SLNO vs ASB Comparison
Compare SLNO & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- ASB
- Stock Information
- Founded
- SLNO 1999
- ASB 1861
- Country
- SLNO United States
- ASB United States
- Employees
- SLNO N/A
- ASB N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ASB Major Banks
- Sector
- SLNO Health Care
- ASB Finance
- Exchange
- SLNO Nasdaq
- ASB Nasdaq
- Market Cap
- SLNO 3.8B
- ASB 4.4B
- IPO Year
- SLNO 2014
- ASB N/A
- Fundamental
- Price
- SLNO $52.75
- ASB $26.30
- Analyst Decision
- SLNO Strong Buy
- ASB Hold
- Analyst Count
- SLNO 10
- ASB 11
- Target Price
- SLNO $112.50
- ASB $27.64
- AVG Volume (30 Days)
- SLNO 1.9M
- ASB 1.2M
- Earning Date
- SLNO 11-05-2025
- ASB 10-23-2025
- Dividend Yield
- SLNO N/A
- ASB 3.52%
- EPS Growth
- SLNO N/A
- ASB N/A
- EPS
- SLNO N/A
- ASB 0.78
- Revenue
- SLNO $32,656,999.00
- ASB $1,035,964,000.00
- Revenue This Year
- SLNO N/A
- ASB $56.79
- Revenue Next Year
- SLNO $175.39
- ASB $5.69
- P/E Ratio
- SLNO N/A
- ASB $33.37
- Revenue Growth
- SLNO N/A
- ASB 3.82
- 52 Week Low
- SLNO $41.50
- ASB $18.32
- 52 Week High
- SLNO $90.32
- ASB $28.18
- Technical
- Relative Strength Index (RSI)
- SLNO 24.40
- ASB 54.70
- Support Level
- SLNO $50.63
- ASB $25.99
- Resistance Level
- SLNO $72.99
- ASB $27.04
- Average True Range (ATR)
- SLNO 4.32
- ASB 0.48
- MACD
- SLNO -1.06
- ASB -0.06
- Stochastic Oscillator
- SLNO 9.34
- ASB 20.07
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.